The shareholders in Enzymatica AB are hereby summoned to the Annual General Meeting, to be held on April 21, 2015 at 16.00 at Ideon Gateway, Ideon, Scheelevägen 27 in Lund, Sweden.
The complete notice is available in Swedish only.
For more information, please contact:
Tina Dackemark Lawesson, Senior Communications Officer Enzymatica AB
Phone: 0706-37 12 58. E-post: tina.lawesson@enzymatica.com
About Enzymatica AB
Enzymatica AB (publ) develops and sells medical technology products based on an enzyme from deep-sea cod. Our development includes medical devices in upper respiratory infections and oral health, and veterinary products in oral health and dermatology. The launched medical portfolio includes ColdZyme® against common colds. The company is headquartered in Lund, Sweden, and is listed on Aktietorget. For more information, please visit www.enzymatica.com.